The 340B Drug Discount Program Is Fulfilling Its Original Purpose
The debate over the future of the 340B drug pricing program has reached a critical new phase. Several members of Congress introduced legislation that would make dramatic changes in the 26-year-old statute, Congress is holding hearings on the program and the Trump administration has offered new proposals in its fiscal 2019 budget. Some have questioned…